The Legendary Debate

Warren Buffett: leans back in his chair "Well, we've all looked at JPM. Let me start with the big question—if we had to hold this business for 20 years, would we sleep well at night? Not just because it's big and important, but because its competitive position is actually strengthening."

Charlie Munger: "That depends entirely on whether you believe the regulatory moat is a durable advantage or a temporary barrier. JPMorgan's scale in compliance and risk management isn't something a fintech startup can replicate easily. But the real question is whether this creates a culture of bureaucracy that eventually strangles innovation. I've seen it happen at other regulated monopolies—the advantage becomes a crutch."

Dev Kantesaria: "I'll answer Warren's question directly: No, I wouldn't sleep well. This isn't about tonight or next year—it's about the fundamental nature of banking. JPMorgan exists at the intersection of three uncontrollable variables: interest rates, credit cycles, and regulatory whims. No matter how good Jamie Dimon is, he can't control the yield curve. This is the opposite of the quality compounders I want—businesses where outcomes are predictable decade after decade."

David Tepper: "Dev's right about the cyclicality, but he's missing the asymmetry. The real question isn't whether JPMorgan will exist in 20 years—it will. The question is whether it can earn more than its cost of capital through cycles. Looking at banking history, the winners aren't the smartest traders but the best allocators. JPM's corporate banking franchise gives them proprietary data flows that even the big tech companies don't have."

Robert Vinall: "David makes an excellent point about data advantages. To Warren's original question—would I sleep well? I would if I trusted their reinvestment runway. JPMorgan's technology budget is larger than most tech companies'. They're not just keeping lights on; they're building proprietary systems that process payments faster, detect fraud better, and price risk more accurately than competitors. That's a reinvestment moat that compounds."

Mohnish Pabrai: "But Robert, let me push back on that reinvestment thesis. Banking is what I call a 'leaky bucket' business—you pour capital in, but so much leaks out through write-offs, regulatory changes, and competitive pressure. Even if they invest $15 billion annually in tech, will they earn 20% returns on that capital? Or will it just be the cost of staying in business? I've studied capital allocation for decades—the best businesses don't need massive reinvestment just to maintain position."

Pulak Prasad: "Mohnish raises the crucial evolutionary question. In nature, organisms that survive aren't the strongest but the most adaptable. JPMorgan has survived the Panic of 1907, the Great Depression, 2008, and COVID. That's remarkable Darwinian fitness. But survival isn't the same as thriving. The test is whether they can evolve faster than the environment changes—whether fintechs, private credit, or CBDCs become existential threats."

Warren Buffett: "Charlie mentioned regulatory moat—that's worth exploring. When I look at JPMorgan, I see something like the railroad business. The barriers to entry are enormous, the regulation is intense, but if you're the best operator, you can earn good returns. The question is whether Jamie Dimon's successor will maintain that operational excellence."

Dev Kantesaria: "Warren, that's exactly my concern. You're comparing them to railroads, but even railroads have predictable cash flows once built. Banking has this inherent leverage that creates nonlinear outcomes. One credit decision that represents 0.1% of their loan book can wipe out years of profits. The Wells Fargo account scandal showed how culture can deteriorate unexpectedly. I'd rather own See's Candies—where a bad batch of chocolate doesn't bankrupt the company."

Charlie Munger: "Dev's not wrong about the risk, but he's underestimating the power of the franchise. When I think about JPMorgan, I think about the fact that Fortune 500 companies don't change their primary banking relationship lightly. The switching costs are enormous—it's not just about rates, it's about integrated treasury systems, global reach, and reliability. That creates a stickyness that's valuable."

David Tepper: "But Charlie, that stickiness is being attacked from both ends. Apple Pay and Goldman Sachs are going after consumers. Private credit funds are going after corporate lending. The middle—where JPM makes money—is being hollowed out. I've seen this pattern in other industries—the incumbents think they're protected until suddenly they're not."

Robert Vinall: "David, you're describing the surface-level disruption, but you're missing the infrastructure layer. Who clears the transactions for Apple Pays of the world? Who provides the custody for the private credit funds? JPMorgan's securities services business has $30 trillion in assets under custody. That's not going away—it's becoming more valuable as financial complexity increases."

Mohnish Pabrai: "Let me ask a different question: What's the bear case that keeps you up at night? For me, it's not fintech or competition—it's the unknown unknown. The thing we're not talking about because we can't see it yet. In 2006, we weren't talking about subprime mortgages bringing down the system. What's the equivalent lurking in JPM's balance sheet today?"

Pulak Prasad: "Mohnish has put his finger on the evolutionary challenge. The dinosaurs didn't see the meteor coming. For JPMorgan, the meteor might be central bank digital currencies disintermediating commercial banking, or AI destroying their advisory margins, or a geopolitical event that fractures the global financial system. The question isn't whether they can survive—it's survived worse—but whether they'll earn good returns afterward."

Warren Buffett: "Well, we've danced around the qualitative questions. Let's look at the numbers—what does the 10-year history tell us about this business quality? I'm particularly interested in how they've performed through cycles."

Charlie Munger: "The numbers show exactly what we'd expect from a cyclical business—ROE bouncing between 8% and 15%, never consistently above 15% for long. That's the nature of banking—you can't escape the cycle. The question is whether the troughs are getting shallower or deeper."

Dev Kantesaria: "Charlie's being generous. Look at the consistency of returns—JPMorgan's ROE has been more volatile than the average industrial company. In 2020, it dropped to single digits. In good years, it might hit 15-16%. But where's the compounding? Where's the upward trajectory? This is why I avoid banks—you get all the risk of capitalism with none of the rewards of compounding machine."

David Tepper: "Dev, you're missing the capital return story. Over the past decade, JPMorgan has returned over $150 billion to shareholders through buybacks and dividends. That's real cash returned, not accounting earnings. The question is whether they can continue that while maintaining their CET1 ratio above regulatory minimums."

Robert Vinall: "David makes a good point about capital return, but let's talk about the reinvestment side. Their technology spend has grown from $7 billion to $15 billion annually over the past five years. The question is what return they're getting on that investment. If they're earning even 15% on that $15 billion, that's $2.25 billion in incremental earnings—that's the compounding engine."

Mohnish Pabrai: "Robert, that's a heroic assumption. Most technology spending is maintenance capex—keeping the lights on, complying with regulations, fighting cyber threats. The incremental return on tech spend is probably low single digits at best. I'd want to see the actual ROI, not assume it."

Pulak Prasad: "Looking at the longer-term trends, what interests me is the efficiency ratio. It's improved from the 60s to the 50s over the past decade. That's meaningful operational improvement. But the question is whether this is sustainable or whether technology costs will inevitably rise faster than revenues."

Warren Buffett: "Let's talk about the current price. At around $300 per share, with EPS of $20 and negative free cash flow due to their business model, how do we think about valuation?"

Dev Kantesaria: "The valuation question is simple for me—I don't value cyclical businesses on earnings because earnings are ephemeral. I'd want to see a price below tangible book value to account for the cyclicality. At current prices, you're paying a significant premium to book for a business that can't control its own destiny."

David Tepper: "I agree with Dev on this one. At 15 times earnings, you're paying for perfection. There's no margin of safety here. If we hit a recession and earnings drop to $12-15, suddenly you're at 20-25 times earnings. I've seen this movie before—it doesn't end well."

Robert Vinall: "I think you're both being too pessimistic. If you normalize earnings over the cycle at around $18-20, and give them a multiple of 12-13 times for a high-quality bank, you get to $220-260. So at $300, I'd want to see a pullback to the $250 range."

Mohnish Pabrai: "I'd be more aggressive—I'd want to see $200 or below. This isn't a compounder; it's a cyclical. You need to buy cyclicals at trough valuations, not mid-cycle valuations. The asymmetry isn't there at current prices."

Pulak Prasad: "I'd be interested around $240-250. That would give us a 10% earnings yield on normalized earnings, which provides some buffer for the cyclicality and regulatory risks."

Charlie Munger: "I'd want to see a price where the dividend yield gets to 3.5-4%. That usually coincides with attractive entry points for financials."

Warren Buffett: "So we have a range from 'avoid entirely' to 'buy at $200-260.' Let me hear everyone's final stance with conviction levels."

Dev Kantesaria: "Avoid entirely. Conviction 10/10. This is the wrong business model for long-term compounding—too much risk, too little control over outcomes."

David Tepper: "Avoid. Conviction 8/10. No asymmetric opportunity here—too much macro risk priced too optimistically."

Robert Vinall: "Buy below $250. Conviction 7/10. The reinvestment in technology and operational excellence will eventually translate to superior returns."

Mohnish Pabrai: "Buy below $200. Conviction 7/10. Only at prices that provide significant margin of safety for the cyclical risks."

Pulak Prasad: "Buy below $240. Conviction 6/10. The Darwinian resilience is valuable, but not at current prices."

Charlie Munger: "Buy below $220. Conviction 8/10. The franchise value is real, but the price needs to reflect the cyclicality."

Warren Buffett: "I'd be interested below $230. Conviction 8/10. This is a well-run institution, but banking will always be a business where you want a significant margin of safety."

Warren Buffett: surveys the room "Let me try to synthesize where we've landed after this discussion. On the qualitative side, we have fundamental agreement that JPMorgan possesses a durable franchise with real competitive advantages in scale, regulatory complexity, and customer stickiness. The corporate banking relationships and global infrastructure create barriers that would cost tens of billions to replicate.

Where we diverge is on the fundamental nature of the business model. Dev and David see a cyclical capital-intensive business where outcomes are determined by factors outside management's control—interest rates, credit cycles, regulatory changes. The rest of us see a superior operator that can navigate these cycles and earn excess returns over time.

The financial history supports both views—the ROE volatility shows the cyclicality, while the consistent capital returns and improving efficiency ratios show operational excellence. The current price at $297 reflects more optimism than I'm comfortable with given the macro uncertainties.

We have five of us who would buy at lower prices ranging from $200-260, with two who would avoid entirely. The majority view is that JPMorgan is a high-quality institution that's currently priced too richly for the risks involved. The minority view is that no price justifies the fundamental risks of the banking model.

Where I land is that at the right price—below $230 for me—JPMorgan represents a good risk-reward opportunity. But as Charlie often says, the first rule is don't lose money, and at current prices, the risk of permanent loss is too high for my taste. Reasonable investors can disagree on this one, and on this call, they clearly do."